Alex A. Adjei

Dr. Adjei is a consultant in Oncology, Professor of Oncology, and Professor of Pharmacology at the Mayo Clinic and Mayo College of Medicine in Rochester, MN. Dr. Adjei oversees oncology drug development as well as lung cancer research and treatment across all three Mayo Clinic sites, and is co-Leader of the Developmental Therapeutics program at Mayo Cancer Center. He has served as the PI on over 70 Phase I trials, as well as over 20 Phase II developmental trials for lung cancer therapy. Dr. Adjei received his MD from the University of Ghana and his PhD in Pharmacology from the University of Alberta, with an internal medicine residency at Howard University and a medical oncology fellowship at Johns Hopkins University.